Icon doubles storage capacity; AstraZeneca signs genomics deal with Foundation Medicine;

> Cmed is moving into a new facility in Durham, NC, giving it 50% more space. News

> French CMO Synerlab has acquired Lyofal, which specializes in outsourcing lyophilization services for R&D, formulation and manufacturing. Story

> Icon ($ICLR) has expanded its biorepository capacity at its Farmingdale, NY, facility, doubling its global storage capabilities. More

> Innovent Biologics is spending $25 million to grow its pipeline and manufacturing capabilities in Suzhou, China. Article

> After some high-profile outsourcing missteps have tanked drugmakers' ambitions, pharma companies and the FDA are struggling to keep tabs on CROs. Item

> AstraZeneca ($AZN) has signed a deal with Foundation Medicine to discover genomic alterations that will help steer decision-making in cancer R&D. Report

Suggested Articles

Major CRO player Pharmaceutical Product Development is set to go back on the public markets after announcing its IPO plans.

Dubbed “Project Nightingale,” the efforts were announced amid concerns and federal inquiries into the data’s safekeeping and patient consent for use.

Independent site management organization Panthera Biopartners has kick-started its first clinical trial in the U.K.